Percentage of patients with PCR-positive nasopharyngeal samples from inclusion to day6 post-inclusion in COVID-19 patients treated
with hydroxychloroquine only, in COVID-19 patients treated with hydroxychloroquine and azithomycin combination, and in COVID-19 control patients.
CORONAVIRUS Covid-19: ecco il link al testo originale sui risultati ottenuti in Francia nella cura del covid-19 con l’utilizzo di una combinazione di idroclorochinina e azitomicina ed il video nel quale vengono spiegati.
For more information
IHU Méditerranée Infection
Hydroxychloroquine and azithromycin as a treatment of COVID-19
Link…
Gautret et al. (2020) Hydroxychloroquine and azithromycin as a treatment of COVID‐19: results of an open‐label non‐randomized clinical trial. International Journal of Antimicrobial Agents – In Press 17 March 2020 – DOI : 10.1016/j.ijantimicag.2020.105949
Link…
MDN
This post is also available in:
Inglese
